Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam−β-Lactamase Inhibitor Combination

Impeding, as well as reducing, the burden of antimicrobial resistance in Gram-negative pathogens is an urgent public health endeavor. Our current antibiotic armamentarium is dwindling, while major resistance determinants (e.g., extended-spectrum β-lactamases [ESBLs]) continue to evolve and dissemina...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Papp-Wallace, Krisztina M., Bethel, Christopher R., Caillon, Jocelyne, Barnes, Melissa D., Potel, Gilles, Bajaksouzian, Saralee, Rutter, Joseph D., Reghal, Amokrane, Shapiro, Stuart, Taracila, Magdalena A., Jacobs, Michael R., Bonomo, Robert A., Jacqueline, Cédric
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2019
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496078/
https://ncbi.nlm.nih.gov/pubmed/30858223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00105-19
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items